• Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination

  • Sep 30 2024
  • Length: 17 mins
  • Podcast

Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination

  • Summary

  • Dr Zachary Zumsteg (Cedars-Sinai Medical Center, Los Angeles, CA, USA) discusses his Review on the challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations.

    Read the full Article:
    https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00264-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc

    Tell us what you thought about this episode

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.